LANGERHANS CELL HISTIOCYTOSIS (LCH)
Clinical trials for LANGERHANS CELL HISTIOCYTOSIS (LCH) explained in plain language.
Never miss a new study
Get alerted when new LANGERHANS CELL HISTIOCYTOSIS (LCH) trials appear
Sign up with your email to follow new studies for LANGERHANS CELL HISTIOCYTOSIS (LCH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare immune disorder: targeted drug added to standard chemotherapy
Disease control Recruiting nowThis study is testing if adding a new targeted drug called luvometinib to standard chemotherapy works better for children with a serious form of Langerhans cell histiocytosis (LCH), a rare immune system disorder. The trial will enroll 120 children across multiple hospitals and ra…
Matched conditions: LANGERHANS CELL HISTIOCYTOSIS (LCH)
Phase: NA • Sponsor: West China Second University Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New drug trial offers hope for kids with rare, dangerous blood disease
Disease control Recruiting nowThis study is testing an oral drug called mirdametinib for people with rare histiocytic disorders like Langerhans Cell Histiocytosis (LCH). It aims to see if this targeted treatment works better and has fewer side effects than current chemotherapy, especially for patients whose d…
Matched conditions: LANGERHANS CELL HISTIOCYTOSIS (LCH)
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
New pill offers hope for kids with rare bone disease, could replace harsh chemo
Disease control Recruiting nowThis study is testing a daily pill called luvometinib for children with a rare bone disease called Langerhans Cell Histiocytosis (LCH). The goal is to see if this targeted pill can control the disease better and with fewer side effects than the standard chemotherapy treatment. Re…
Matched conditions: LANGERHANS CELL HISTIOCYTOSIS (LCH)
Phase: NA • Sponsor: West China Second University Hospital • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC